RUNX2 and cleidocranial dysplasia 1: Furthermore, mRNA levels of CTR, TRAP and CTSK were reduced to 38%, 14% and 49% in CCD hDFCs compared with the levels in control hDFCs (Fig. 3b–d), showing a pattern of expression similar to that of RUNX2 (Fig. 3a).